Molecularly Characterised Xenograft Tumour Mouse Models: Valuable Tools for Evaluation of New Therapeutic Strategies for Secondary Liver Cancers

Figure 4

Immunohistochemical analysis of original and corresponding xenograft tumour AKH23. Sections were stained with (a), (b) antibodies specific for CEA, (c), (d) cytokeratin 8/18, and (e), (f) cytokeratin 20. (a) Arrows indicate few stained cells in the original tumour AKH23 reacting with the CEA-specific antibody. Magnification: 200x.

(a)

(b)

(c)

(d)

(e)

(f)